Education
About Us
Working with TipRanks
Follow Us
IDT Australia Limited (AU:IDT)
ASX:IDT
IDT Stock Chart & Stats
AU$0.05
>-AU$0.01(-1.87%)
At close: 4:00 PM EST
AU$0.05
>-AU$0.01(-1.87%)
Day’s Range― - ―
52-Week RangeAU$0.05 - AU$0.13
Previous CloseN/A
Volume22.00K
Average Volume (3M)336.94K
Market Cap
AU$22.21M
Enterprise ValueAU$47.64M
Total Cash (Recent Filing)AU$4.11M
Total Debt (Recent Filing)AU$10.40M
Price to Earnings (P/E)―
Beta1.02
Next Earnings
Feb 24, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding427,425,570
10 Day Avg. Volume373,970
30 Day Avg. Volume336,941
Financial Highlights & Ratios
PEG Ratio-0.21
Price to Book (P/B)1.73
Price to Sales (P/S)1.92
P/FCF Ratio-5.03
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
IDT Australia Limited News
IDT FAQ
What was IDT Australia Limited’s price range in the past 12 months?
IDT Australia Limited lowest share price was AU$0.05 and its highest was AU$0.13 in the past 12 months.
What is IDT Australia Limited’s market cap?
IDT Australia Limited’s market cap is AU$22.21M.
When is IDT Australia Limited’s upcoming earnings report date?
IDT Australia Limited’s upcoming earnings report date is Feb 24, 2026 which is in 63 days.
How were IDT Australia Limited’s earnings last quarter?
IDT Australia Limited released its earnings results on Aug 20, 2025. The company reported -AU$0.011 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.011.
Is IDT Australia Limited overvalued?
According to Wall Street analysts IDT Australia Limited’s price is currently Overvalued.
Does IDT Australia Limited pay dividends?
IDT Australia Limited pays a Semiannually dividend of AU$0.008 which represents an annual dividend yield of N/A. See more information on IDT Australia Limited dividends here
What is IDT Australia Limited’s EPS estimate?
IDT Australia Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does IDT Australia Limited have?
IDT Australia Limited has 427,425,570 shares outstanding.
What happened to IDT Australia Limited’s price movement after its last earnings report?
IDT Australia Limited reported an EPS of -AU$0.011 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.449%.
Which hedge fund is a major shareholder of IDT Australia Limited?
Currently, no hedge funds are holding shares in AU:IDT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
IDT Australia Limited Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
― (―)
― (―)
Blogger Sentiment
Bullish
AU:IDT Sentiment 75%
Sector Average ―
Sector Average ―
Insider Transactions
Bought Shares
Worth AU$5.1K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-52.80%
12-Months-Change
Fundamentals
Return on Equity
-35.58%
Trailing 12-Months
Asset Growth
17.69%
Trailing 12-Months
Company Description
IDT Australia Limited
IDT Australia Limited (IDT) is a pharmaceutical company based in Australia, specializing in the development and manufacturing of a diverse range of pharmaceutical products. The company operates primarily in the pharmaceutical sector, focusing on contract manufacturing services, as well as the development of its own proprietary products. IDT offers a broad array of services including formulation development, clinical trial manufacturing, and commercial production for both domestic and international clients. Its core products encompass a variety of dosage forms, including oral solids, sterile injectables, and topical formulations.
Technical Analysis
Next Science Ltd
―
Little Green Pharma Ltd.
―
Medical Developments International Limited
―
Althea Group Holdings Ltd.
―
Cronos Australia Ltd.
―
Options Prices
Currently, No data available
---